ArticlePloS one2026
Machine learning-supported identification of necrosis in colorectal and pancreatic cancer spheroids.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
significanceThe transition to three-dimensional cell models is a reality in cancer research. While these models are more physiologically relevant, they present challenges that have not been previously considered. Certain aspects of 3D cultures, such as cell death, need to be modelled as they have a profound impact on spheroid survival and therefore on cancer treatment testing.
aimTo identify necrosis in HT-29 and Hs766-T cancer spheroids using an accurate, cost-effective, and fast machine learning-based system that relies only on brightfield (BF) images. APPROACH: In this study, three staining procedures with dyes were performed in colorectal and pancreatic cancer spheroids to highlight necrosis. The microscopic images of these stains serve as a ground truth for different machine learning models, which can subsequently learn to detect necrosis from the brightfield image, i.e., without the need for staining.
resultsThe results show a strong correlation between dark spots in the spheroid and their staining as necrotic, making regression models an appropriate solution. In general, the supervised models performed better than the unsupervised ones. The models perform worse in all cases for pancreatic Hs-766T spheroids, where necrosis is manifested as small, scattered spots, as opposed to colorectal HT-29 spheroids, where necrosis is a larger cluster in the center. The U-Net regression models demonstrated particularly noteworthy performance, at times surpassing 90% Normalized Coefficient of Correlation.
conclusionsThe study findings demonstrate the potential for modeling necrosis in spheroids to a certain extent using 2D microscopy images and machine learning identification. The accuracy of the models largely depends on the manifestation of the necrosis, that is, the specific cancer cells that make up the spheroids.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.